Showing results (41-50 of 284) with videos related to
Sort By:
Pageof 29
ACS Medicinal Chemistry Letters|March 19, 2025
Identification of Indazole- and Azaindazole-Substituted Cyclopentapyrroles as G2019S Leucine-Rich Repeat Kinase 2 Inhibitors for the Treatment of CNS DisordersSiyan Feng, Steven H LiangACS Medicinal Chemistry Letters|April 16, 2025
Novel Pyrazolo[1,5-a]pyrimidine-3,5-diamines as nSMase2 InhibitorsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|March 18, 2026
Novel Macrocyclic Compounds Targeting KRAS Mutations for Cancer TreatmentLingxin Meng, Steven H LiangACS Medicinal Chemistry Letters|March 18, 2026
Novel Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion-Selective Inhibitors for Lung Cancer TherapyYanwei Jiang, Steven H LiangACS Medicinal Chemistry Letters|March 18, 2026
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6Yinlong Li, Steven H LiangACS Medicinal Chemistry Letters|May 20, 2026
Discovery of Novel Benzothiazole-Based PDE4 Inhibitors for Central Nervous System DisordersLingxin Meng, Steven H LiangACS Medicinal Chemistry Letters|May 20, 2026
Novel 1‑Phenyl-2,3-dihydroquinazolin-4(1H)-one Derivatives as Nav 1.8 Voltage-Gated Sodium Channels InhibitorsRuihu Song, Steven H LiangACS Medicinal Chemistry Letters|May 20, 2026
Novel Pyrido[4,3‑d]pyrimidine Derivatives as Kirsten Rat Sarcoma (KRAS) G12C Potential InhibitorsRuihu Song, Steven H LiangACS Medicinal Chemistry Letters|July 14, 2026
Novel Substituted Heterocyclic Carboxamindes as α2C-ARs AntagonistsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|July 14, 2026
Pyridine Derivatives as Cyclin-Dependent Kinase Inhibitors for the Treatment of CancerYanwei Jiang, Steven H LiangPageof 29